Hedge Fund - OrbiMed Advisors
Eli Lilly & Co (LLY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q4 (2024-12-31) | $260,627,200 | 5.36% | 337,600 | $828.01 |
| 2 | 2024 - Q3 (2024-09-30) | $299,093,344 | 5.43% | 337,600 | $899.05 |
| 3 | 2024 - Q2 (2024-06-30) | $305,656,288 | 6.03% | 337,600 | $799.92 |
| 4 | 2024 - Q1 (2024-03-31) | $280,687,968 | 5.14% | 360,800 | $711.67 |
| 5 | 2023 - Q4 (2023-12-31) | $212,998,968 | 4.25% | 365,400 | $583.70 |
| 6 | 2023 - Q3 (2023-09-30) | $99,906,180 | 2.12% | 186,000 | $515.29 |
| 7 | 2023 - Q2 (2023-06-30) | $87,230,280 | 1.58% | 186,000 | $419.37 |
| 8 | 2023 - Q1 (2023-03-31) | $63,876,120 | 1.25% | 186,000 | $337.26 |
| 9 | 2018 - Q1 (2018-03-31) | $0 | 0% | 0 | $80.50 |
| 10 | 2017 - Q4 (2017-12-31) | $193,244,000 | 2.44% | 2,288,000 | $85.09 |
| 11 | 2017 - Q3 (2017-09-30) | $263,036,000 | 2.51% | 3,075,000 | $82.02 |
| 12 | 2017 - Q2 (2017-06-30) | $253,073,000 | 2.65% | 3,075,000 | $81.58 |
| 13 | 2017 - Q1 (2017-03-31) | $280,103,000 | 3.17% | 3,330,200 | $80.10 |
| 14 | 2016 - Q4 (2016-12-31) | $201,453,000 | 2.56% | 2,739,000 | $74.47 |
| 15 | 2016 - Q3 (2016-09-30) | $163,771,000 | 1.86% | 2,040,500 | $80.04 |
| 16 | 2016 - Q2 (2016-06-30) | $116,298,000 | 1.21% | 1,476,800 | $75.29 |
| 17 | 2016 - Q1 (2016-03-31) | $182,999,000 | 1.92% | 2,541,300 | $75.67 |
| 18 | 2015 - Q4 (2015-12-31) | $135,911,000 | 1.23% | 1,613,000 | $82.99 |
| 19 | 2015 - Q3 (2015-09-30) | $106,454,000 | 1.07% | 1,272,000 | $84.42 |
| 20 | 2014 - Q4 (2014-12-31) | $0 | 0% | 0 | $67.50 |
| 21 | 2014 - Q3 (2014-09-30) | $7,263,000 | 0.07% | 112,000 | $63.31 |
| 22 | 2014 - Q2 (2014-06-30) | $24,868,000 | 0.29% | 400,000 | $59.66 |
| 23 | 2014 - Q1 (2014-03-31) | $31,961,000 | 0.39% | 543,000 | $55.81 |
The displayed share prices are average quarterly stock market prices.